WEST PHARMACEUTICAL SERVICES INC — Director's Dealing 2024

Feb 22, 2024

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: WEST PHARMACEUTICAL SERVICES INC (WST)
CIK: 0000105770
Period of Report: 2024-02-20

Reporting Person: Reiss-Clark Cindy (Chief Commercial Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2024-02-20	Common Stock	A	551	—	Acquired	4884.346	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2024-02-20	Stock Options (Right to Buy)	$350.18	A	2411	Acquired	2034-02-20	Stock Options (Right to Buy) (2411)	Direct

Footnotes

F1: 2021 PSUs (PP20) award vesting net of taxes withheld.

F2: This grant vests in four equal installments beginning on February 20, 2025.